Related Experiment Videos
[Threatened extension of myocardial infarction in situ and coronary spasm]
Insights
Recurrent coronary artery spasm can cause myocardial infarction (MI) spread by causing intermittent blood flow reduction. Early diagnosis and treatment with vasodilators and angiography are crucial for managing this condition.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Interventional Cardiology
Background:
- Myocardial infarction (MI) is a critical cardiovascular event.
- Understanding the mechanisms of MI extension is vital for patient outcomes.
Observation:
- A case of threatened myocardial infarction (MI) spread occurred 4 days post-MI.
- The event involved the same myocardial territory as the initial infarction.
Findings:
- Coronary angiography revealed spontaneous occlusive spasm of the right coronary artery.
- This spasm recurred with angina and ST elevation in the infarcted area.
- Intermittent coronary occlusion due to repeated spasm may contribute to in situ MI spread.
Implications:
- This mechanism can lead to incomplete myocardial necrosis and threaten viable myocardium.
- Treatment involves coronary-dilating medications (nitrates, calcium inhibitors).
- Early coronary angiography with pharmacodynamic testing is recommended to assess surgical candidacy.
Abstract:
The authors report a case of threatened spread occurring 4 days after posterior-inferior myocardial infarction and involving the same territory. The spontaneous occurrence during coronary angiography of an occlusive spasm of the right coronary artery with recurrence of angina and ST elevation in the area of initial necrosis suggests that this mechanism might be the contributory factor to the threat of in situ spread. Thus intermittent coronary occlusion from repeated spasm can bring about incomplete necrosis of the area of dependent myocardium and by extension threaten the viability of groups of still healthy cells. A syndrome of this kind initially requires coronary-dilating medical treatment, with nitrate derivatives and calcium inhibitors and then early coronary angiography with the use of pharmacodynamic tests to assess the suitability of surgery.